Overview

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

Status:
Completed

Trial end date:
2008-09-20

Target enrollment:

Participant gender:

Summary

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline